Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years
AuthID
P-00R-VX9
P-00R-VX9
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service